FDA Grants Datopotamab Deruxtecan Approval for ...

By Rene Pretorius

January 24, 2025

The FDA approved datopotamab deruxtecan (Datrow...
MPA Meningioma Risk: Key Insights and Implications
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
Promising Dual Immunotherapy for Anaplastic Thyroid Cancer
Valuable, Cost-Effective Thyroid Cancer Diagnosis
WHO Prequalifies First G6PD Diagnostic Test
Diabetes Drugs Safe from Thyroid Cancer Risk, Study Finds
Abu Dhabi Introduces WINREVAIR: A Major Breakthrough in Pulmonary Arterial Hy...
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Transforming Cancer Care in Abu Dhabi
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer